Global and United States Botulinum Toxin Injection Market Report & Forecast 2022-2028

Botulinum toxin is a protein that helps stop muscle spasms when it is injected directly into the muscle. Muscle spasms are caused by chemical messages sent to the muscles from nerves. These messages tell the muscles to contract (to tighten up). Botulinum toxin blocks these messages.
Market Analysis and Insights: Global and United States Botulinum Toxin Injection Market
This report focuses on global and United States Botulinum Toxin Injection market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Botulinum Toxin Injection market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Medical Type accounting for % of the Botulinum Toxin Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospital was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Botulinum Toxin Injection market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Botulinum Toxin Injection Scope and Market Size
Botulinum Toxin Injection market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Botulinum Toxin Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Botulinum Toxin Injection market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
Medical Type
Cosmetic Type

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
LIBP
Allergan
Ipsen
Medytox
US WorldMeds
Merz